Safety of Oral Vancomycin in Functionally Anephric Patients
Administration of a vancomycin oral solution, 2 g daily for 16 days, to functionally anephric patients without inflammatory bowel disease resulted in assayable but low (≤0.66 μg/ml) serum levels in two of the five volunteers.
Збережено в:
| Опубліковано в:: | Antimicrob Agents Chemother |
|---|---|
| Автори: | , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
American Society for Microbiology (ASM)
1978
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352521/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/718158/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.14.4.634 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|